Researchers have demonstrated the production, purification, and potential application of cerium-134. The isotope decays into lanthanum-134, which is useful for positron emission tomography (PET) imaging. The results mean that cerium-134 could support medical treatments based on actinium-225 or thorium-227.
Today, the U.S. Department of Energy (DOE) announced $4 million in funding for 10 awards across 5 efforts to advance R&D for isotope production. This funding is part of a key federal program that produces critical isotopes otherwise unavailable or in short supply for U.S. science, medicine, and industry.
The U.S. Department of Energy (DOE) announced up to $2 million in new funding to support translational research and development (R&D) of novel, medically relevant isotopes to accelerate evaluation for usage in pre-clinical and clinical trials.
Today, the U.S. Department of Energy (DOE) announced up to $2 million to establish a traineeship program to advance workforce development in the field of isotope production, processing, and associated research, with preference to minority serving institutions.
University of Alabama Birmingham professor Suzanne Lapi founded and heads a research group focused on the radiochemistry and development of production techniques of isotopes for medical imaging and therapy.
Researchers from Berkeley Lab and Los Alamos National Laboratory have developed new methods for the large-scale production, purification, and use of the radioisotope cerium-134, which could serve as a PET imaging radiotracer for a highly targeted cancer treatment known as alpha-particle therapy.
Mars 2020 will be the first NASA mission that uses ORNL-produced plutonium-238, the first U.S.-produced Pu-238 in three decades. ORNL’s Pu-238 will help power Perseverance across the Red Planet’s surface.